1st Circ. Revives Sanofi Insulin Injector Antitrust Case
The First Circuit has revived a proposed class action against Sanofi-Aventis, saying the pharmaceutical company must prove it acted in good faith when it wrongly placed a patent for an insulin...To view the full article, register now.
Already a subscriber? Click here to view full article